These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 34221348)
1. Clozapine re-challenge and initiation following neutropenia: a review and case series of 14 patients in a high-secure forensic hospital. Silva E; Higgins M; Hammer B; Stephenson P Ther Adv Psychopharmacol; 2021; 11():20451253211015070. PubMed ID: 34221348 [TBL] [Abstract][Full Text] [Related]
2. [Clozapine rechallenge after neutropenia in resistant schizophrenia: A review]. Simon L; Cazard F Encephale; 2016 Aug; 42(4):346-53. PubMed ID: 27109327 [TBL] [Abstract][Full Text] [Related]
3. Optimizing outcomes in clozapine rechallenge following neutropenia: a cohort analysis. Meyer N; Gee S; Whiskey E; Taylor D; Mijovic A; Gaughran F; Shergill S; MacCabe JH J Clin Psychiatry; 2015 Nov; 76(11):e1410-6. PubMed ID: 26646037 [TBL] [Abstract][Full Text] [Related]
4. Clozapine rechallenge or continuation despite neutropenia or agranulocytosis using colony-stimulating factor: A systematic review. Corbeil O; Béchard L; Fournier É; Plante M; Thivierge MA; Lafrenière CÉ; Huot-Lavoie M; Brodeur S; Essiambre AM; Roy MA; Demers MF J Psychopharmacol; 2023 Apr; 37(4):370-377. PubMed ID: 36794520 [TBL] [Abstract][Full Text] [Related]
5. Clozapine rechallenge and initiation despite neutropenia- a practical, step-by-step guide. Silva E; Higgins M; Hammer B; Stephenson P BMC Psychiatry; 2020 Jun; 20(1):279. PubMed ID: 32503471 [TBL] [Abstract][Full Text] [Related]
6. [Clozapine rechallenge in resistant schizophrenia disorder affecting "super sensitive" patients, after neutropenia under clozapine: a case report]. Huguet G; Lillo-Le Louet A; Darnige L; Loo H; Krebs MO Encephale; 2013 May; 39 Suppl 1():S42-8. PubMed ID: 23557674 [TBL] [Abstract][Full Text] [Related]
8. Use of granulocyte-colony stimulating factor to prevent recurrent clozapine-induced neutropenia on drug rechallenge: A systematic review of the literature and clinical recommendations. Myles N; Myles H; Clark SR; Bird R; Siskind D Aust N Z J Psychiatry; 2017 Oct; 51(10):980-989. PubMed ID: 28747065 [TBL] [Abstract][Full Text] [Related]
9. The Use of Granulocyte Colony-Stimulating Factor in Clozapine Rechallenge: A Systematic Review. Lally J; Malik S; Krivoy A; Whiskey E; Taylor DM; Gaughran FP; Flanagan RJ; Mijovic A; MacCabe JH J Clin Psychopharmacol; 2017 Oct; 37(5):600-604. PubMed ID: 28817489 [TBL] [Abstract][Full Text] [Related]
10. Clozapine Rechallenge or Continuation Despite Neutropenia, an Extended Follow-up of a Consecutive Quebec Case Series. Béchard L; Morasse-Bégis M; Corbeil O; Hakim JR; Malenfant E; Brodeur S; Huot-Lavoie M; Essiambre AM; Demers MF; Roy MA J Clin Psychopharmacol; 2022 Jul-Aug 01; 42(4):391-395. PubMed ID: 35546087 [TBL] [Abstract][Full Text] [Related]
11. Continuing clozapine with granulocyte colony-stimulating factor in patients with neutropenia. Khan AA; Harvey J; Sengupta S Ther Adv Psychopharmacol; 2013 Oct; 3(5):266-71. PubMed ID: 24167701 [TBL] [Abstract][Full Text] [Related]
12. G-CSF mediated neutrophil augmentation in a unique case of comorbid idiopathic Parkinson's disease and treatment-resistant schizophrenia on clozapine. Morrow O; Gibson L; Bhamra M; David AS; Posporelis S Ther Adv Psychopharmacol; 2020; 10():2045125320956414. PubMed ID: 32973999 [TBL] [Abstract][Full Text] [Related]
13. Restarting clozapine after neutropenia: evaluating the possibilities and practicalities. Whiskey E; Taylor D CNS Drugs; 2007; 21(1):25-35. PubMed ID: 17190527 [TBL] [Abstract][Full Text] [Related]
14. Lithium and clozapine rechallenge: a retrospective case analysis. Kanaan RA; Kerwin RW J Clin Psychiatry; 2006 May; 67(5):756-60. PubMed ID: 16841625 [TBL] [Abstract][Full Text] [Related]
15. Use of cytokines in clozapine-induced agranulocytosis. Chin-Yee I; Bezchlibnyk-Butler K; Wong L Can J Psychiatry; 1996 Jun; 41(5):280-4. PubMed ID: 8793147 [TBL] [Abstract][Full Text] [Related]
16. A case report of the successful administration of clozapine in the face of myocardial infarction, pulmonary embolism and hyperlipidaemia resulting in the termination of long-term seclusion. Till A; Silva E BMC Psychiatry; 2019 Jan; 19(1):37. PubMed ID: 30674292 [TBL] [Abstract][Full Text] [Related]
17. Circadian rhythm of neutrophil counts and granulocyte macrophage-colony stimulating factor (GM-CSF) under clozapine treatment: a case report. Ferrea S; Fehsel K; Cordes J; Luckhaus C World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):511-3. PubMed ID: 19396726 [TBL] [Abstract][Full Text] [Related]
18. Utilization of G-CSF and GM-CSF as an alternative to discontinuation in clozapine-induced neutropenia or leukopenia: A case report and discussion. Karst A; Lister J Ment Health Clin; 2018 Sep; 8(5):250-255. PubMed ID: 30206510 [TBL] [Abstract][Full Text] [Related]
19. Clozapine re-challenge under the cover of Filgrastim. Gopalakrishnan R; Subhalakshmi TP; Kuruvilla A; Jacob KS J Postgrad Med; 2013; 59(1):54-5. PubMed ID: 23525060 [TBL] [Abstract][Full Text] [Related]
20. Cerebroventricular clozapine would be a viable treatment modality for clozapine-dependent schizophrenia patients with neutropenia. Alisky JM Med Hypotheses; 2012 Oct; 79(4):497-9. PubMed ID: 22818272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]